10:48 AM EST - Microbix Biosystems Inc. : Announces that its quality assessment products have been selected to support a screening program for Human Papilloma Virus using molecular diagnostic technology across The Netherlands, an EU member-state. Microbix Biosystems Inc.
shares T.MBX are trading unchanged at $0.38.
